Company Monitoring Page for Amgen

latest headlines for company on cafepharma

FDA may limit anemia drug use for kidney disease
Yahoo/AP
Thu, 10/14/10 - 11:03 am
Tags:
anemia, kidney disease, FDA, Amgen, Procrit, Aranesp, Epogen
Is Gilead Sciences a Sell?
Motley Fool
Thu, 10/14/10 - 09:32 am
Tags:
Gilead Sciences, Amgen, Celgene, Genzyme
Updated AMG 386 Data Demonstrate Promising Antitumor Activity in Patients With Recurrent Ovarian Cancer
Yahoo/PR Newswire
Sun, 10/10/10 - 11:55 am
Tags:
AMG 386, Amgen, paclitaxel, ovarian cancer
Actelion Surges on Report It May Be Weighing Selling Itself
Bloomberg
Fri, 10/8/10 - 08:09 am
Tags:
Actelion, M&A, GSK, Roche, Amgen, Bristol-Myers Squibb
FDA delays ruling on Teva version of Amgen drug
Yahoo/AP
Fri, 10/1/10 - 12:16 pm
Tags:
Teva Pharmaceuticals, FDA, neutropenia, generics, Amgen, Neupogen
Amgen Drug May Block Some Breast Cancer, Studies Hint
Bloomberg
Thu, 09/30/10 - 11:24 am
Tags:
Amgen, breast cancer, denosumab
Good News for Hospira
Yahoo/Zacks.com
Mon, 09/27/10 - 12:01 pm
Tags:
Nivestem, Hospira, biosimilars, Amgen
Amgen recalls anemia drugs due to glass flakes
Yahoo/AP
Fri, 09/24/10 - 11:14 am
Tags:
Amgen, anemia, recalls, Epogen, Procrit
Savient Investors Expect a Sale
TheStreet.com
Wed, 09/15/10 - 08:06 am
Tags:
Savient, M&A, gout, FDA, Krystexxa, JNJ, Pfizer, Amgen, Novartis, Bristol-Myers Squibb
Genzyme Cuts Back for Future Gains: Biotechs Must Revert to Lean Growth
Seeking Alpha
Wed, 09/15/10 - 07:37 am
Tags:
layoffs, biotech, Genzyme, Amgen, Biogen Idec, Celgene, Gilead Sciences, Sanofi
Amgen Plans to Sell $1.5 Billion of Bonds in Second Debt Offering of 2010
Bloomberg
Tue, 09/14/10 - 08:07 am
Tags:
Amgen, bonds
The One Thing You Must Know About Amgen
Motley Fool
Fri, 09/10/10 - 09:33 am
Tags:
Amgen, Kevin Sharer, Pharma CEOs
'Multiple Shrinkage' Weighs on Large-Cap Biotech
TheStreet.com
Tue, 09/7/10 - 01:12 pm
Tags:
biotech, Amgen, Celgene, Biogen Idec, Gilead Sciences, Genzyme
Does Amgen Pass Buffett's Test?
Motley Fool
Fri, 09/3/10 - 08:03 am
Tags:
Warren Buffett, Amgen
Why Amgen Should Buy Genzyme
Forbes
Tue, 08/31/10 - 01:03 pm
Tags:
Amgen, M&A, Genzyme, Sanofi
21 Drugs Facing FDA Approval Decisions
TheStreet.com
Tue, 08/31/10 - 12:05 pm
Tags:
FDA, Questcor Pharmaceuticals, Savient, Alkermes, Arena Pharmaceuticals, Roche, Novartis, Hospira, Human Genome, Alexza, Jazz Pharmaceuticals, Biodel, Amylin, Eli Lilly, Vivus, Avanir, Cadence Pharmaceuticals, Amgen, Cumberland, Orexigen, MannKind, Bristol-Myers Squibb
Could Amgen Be a Multibagger?
Motley Fool
Tue, 08/24/10 - 01:09 pm
Tags:
Amgen
How Well Do You Use Cash, Amgen?
Motley Fool
Mon, 08/23/10 - 05:32 pm
Tags:
Amgen, Biogen Idec, Genzyme
Big Pharma's Top 5 Emerging Market Deals
Fierce Pharma
Mon, 08/23/10 - 10:32 am
Tags:
emerging markets, Abbott Laboratories, Piramal Healthcare, India, GSK, Laboratorios Phoenix, Argentina, Novartis, China, Zhejiang Tianyuan Bio-Pharmaceutical, Brazil, Amgen, South Korea, Dong-A Pharma
Dividends Aren't Enough: Biotech
Motley Fool
Sat, 08/21/10 - 10:48 am
Tags:
Gilead Sciences, Amgen, Genzyme, Dendreon, Biogen Idec

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.